Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Last Updated: 10/19/15

Sally Hausman, M.A.

Ms. Sally Hausman

Senior Specialist, R&D Agreements

Sally Hausman is a Senior Specialist for Research and Development Agreements in the Regulatory Affairs Branch. She is responsible for obtaining access to CTEP-sponsored investigational agents on behalf of academic investigators interested in performing preclinical studies, and for executing the Material Transfer Agreements with the investigators’ institutions. She is also responsible for the execution of Material Transfer Agreements for the NCI RAID program. Before coming to the NCI, she spent 14 years as a member of the Pertussis Laboratory at the Center for Biologics Evaluation and Review, FDA. Ms. Hausman has a B.A. in Biological Sciences and an M.A. in Microbiology from Indiana University, Bloomington.

About the Branch Chief

Jan Casadei, PhD Jan Casadei, PhD joined the National Cancer Institute in 1991, where she is now chief of the Regulatory Affairs Branch, CTEP. Her area of expertise covers FDA regulations, policies and guidelines for the conduct of clinical studies with investigational agents. As the chief of the Regulatory Affairs Branch, Dr. Casadei is responsible for facilitating the development of promising investigational anti-cancer agents, by providing regulatory/IND support More…